WASHINGTON (AP) — Senators are asking the Justice Department to investigate whether pharmaceutical company Mylan acted illegally when it classified its life-saving EpiPen as a generic drug and qualified for lower rebate payments to states.
By MARY CLARE JALONICK Associated Press, St. Louis Post-Dispatch: Business
Wed, 09/28/2016 - 10:11am
WASHINGTON (AP) — Senators are asking the Justice Department to investigate whether pharmaceutical company Mylan acted illegally when it classified its life-saving EpiPen as a generic drug and qualified for lower rebate payments to states.